lymphokine-activated killer ( lak ) cells from cultures of human peripheral blood mononuclear cells with recombinant interleukin-2 ( ril-2 ) have been clinically used in adoptive immunotherapy for cancer patients .
C0086418
human
C0021756
recombinant interleukin-2